Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU

February 28, 2023 Medical Communications

Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …
News

MHRA’s authority restored following Northern Ireland Brexit deal

February 28, 2023 Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …
News

FDA sued by US states over abortion pill access

February 27, 2023 Medical Communications

Attorneys general (AGs) from 12 Democrat-led US states have made complaints to the FDA in an attempt to force the …
News

Causeway Therapeutics raises £8.75m for tennis elbow research

February 27, 2023 Medical Communications

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international …
News

AbbVie gains positive CHMP opinion for upadacitinib for the treatment of Crohn’s disease

February 27, 2023 Medical Communications

AbbVie has announced that it has received positive feedback from the EMA’s Committee for Medicinal Products for Human Use (CHMP) …
News

Merck to appeal EU rejection of COVID-19 drug

February 27, 2023 Medical Communications

Life science giant Merck & Co has announced that it will appeal the EU’s Committee for Medicinal Products for Human …
News

Sanofi and Glooko partner on ‘connected insulin’ tech

February 24, 2023 Medical Communications

Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …
News

Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use

February 24, 2023 Medical Communications

US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …
News

NICE approved BMS’s Opdivo for lung cancer

February 24, 2023 Medical Communications

Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …
News

Moda Living and LloydsPharmacy partner to offer residents prescription service

February 24, 2023 Medical Communications

Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP.   VideoGP will …
News

AstraZeneca signs $63m agreement for gastric cancer treatment

February 23, 2023 Medical Communications

AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
News

£1.6bn of research and development funding “surrendered” back to UK Treasury

February 23, 2023 Medical Communications

A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
News

FDA approval granted to BD’s HPV assay for use with ThinPrep Pap Test

February 22, 2023 Medical Communications

Becton, Dickinson and Company (BD) has received FDA approval for its new HPV assay which will be used in testing …
News

Unum UK expands employee digital health app

February 21, 2023 Medical Communications

Employee benefits provider Unum UK has expanded its available modules on its Help@hand app, which aims to provide digital health …
News

CSL receives CMA from the European Commission for haemophilia B drug

February 21, 2023 Medical Communications

CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026